Spyre Therapeutics Inc. (SYRE)
21.57
0.77 (3.70%)
At close: Jan 15, 2025, 1:38 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Net Income | -338.79M | -83.81M | -65.80M | -80.89M | -78.25M | -44.35M | -27.24M | -21.70M | -11.29M | -10.35M |
| Depreciation & Amortization | 744.00K | 1.57M | 1.58M | 996.00K | 901.00K | 293.00K | 249.00K | 132.00K | 89.00K | 19.00K |
| Stock-Based Compensation | 25.68M | 7.11M | 8.04M | 6.26M | n/a | n/a | n/a | n/a | 767.00K | 147.00K |
| Other Working Capital | -5.80M | -2.86M | 768.00K | -2.00M | 4.52M | 3.88M | 1.50M | 976.00K | 533.00K | 191.00K |
| Other Non-Cash Items | 217.67M | 823.00K | 90.00K | 619.00K | 3.78M | 1.93M | 4.77M | 1.07M | 790.00K | 2.82M |
| Deferred Income Tax | n/a | -327.00K | 548.00K | -213.00K | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -5.21M | -5.50M | 1.83M | -2.54M | 7.10M | 7.20M | -198.00K | 1.45M | -1.33M | 26.00K |
| Operating Cash Flow | -99.91M | -80.14M | -53.72M | -75.78M | -65.69M | -32.19M | -24.61M | -18.84M | -10.98M | -7.33M |
| Capital Expenditures | n/a | -38.00K | -573.00K | -4.28M | -1.49M | -422.00K | -619.00K | -212.00K | -208.00K | -181.00K |
| Acquisitions | 3.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -166.80M | -39.50M | -133.08M | -129.00M | -91.93M | -62.18M | -64.11M | -20.39M | -3.77M | n/a |
| Sales Maturities Of Investments | 39.90M | 96.55M | 111.03M | 125.68M | 91.68M | 47.37M | 42.20M | 8.45M | n/a | n/a |
| Other Investing Acitivies | 15.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -40.00K | -40.00K |
| Investing Cash Flow | -108.39M | 57.01M | -22.62M | -7.60M | -1.74M | -15.23M | -22.53M | -12.16M | -4.01M | -221.00K |
| Debt Repayment | -16.00K | -418.00K | -510.00K | -20.00K | -25.00K | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.03M | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 191.98M | 222.00K | 1.90M | 816.00K | 1.45M | 3.02M | 833.00K | 76.00K | 23.00K | n/a |
| Financial Cash Flow | 361.08M | 42.68M | 1.39M | 154.51M | 65.72M | 57.07M | 12.21M | 49.37M | 41.67M | 5.58M |
| Net Cash Flow | 152.80M | 19.44M | -74.96M | 71.18M | -3.21M | 9.64M | -34.93M | 18.37M | 26.68M | -1.98M |
| Free Cash Flow | -99.91M | -80.18M | -54.29M | -80.06M | -67.18M | -32.61M | -25.23M | -19.05M | -11.19M | -7.52M |